Edward McKinley
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Edward McKinley
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Private Company | Pharmaceuticals: Major | 27 | |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO.
16
| Extinct | Pharmaceuticals: Major | 16 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Edward McKinley
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Glycomed, Inc.
 Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Glycomed, Inc. discovers and developes pharmaceuticals based on complex carbohydrates. The company's drug discovery strategy utilizes medicinal chemistry to identify biologically active small molecules for therapeutic use. The company was founded by Brian G. Atwood in 1987 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of Virginia | College/University | Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member Founder | |
| Stanford University | College/University | Masters Business Admin Doctorate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Hoechst Marion Roussel, Inc. | General Counsel Corporate Officer/Principal | ||
| University of Pennsylvania | College/University | Graduate Degree Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| GRITSTONE BIO, INC. | Biotechnology | Founder Chairman | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Founder | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ATRECA, INC. | Biotechnology | Chairman Director/Board Member | |
Clovis Oncology UK Ltd.
 Clovis Oncology UK Ltd. BiotechnologyHealth Technology Part of Clovis Oncology, Inc., Clovis Oncology UK Ltd. is a company that engages in research and development on biotechnology. Clovis Oncology UK Ltd. is based in Cambridge, UK. | Biotechnology | Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Sanford Burnham Prebys Medical Discovery Institute
 Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Chairman Chief Executive Officer | |
Meritage Pharma, Inc.
 Meritage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Meritage Pharma, Inc. develops prescription products for the treatment of gastrointestinal and atopic diseases. The company was founded by Cam L. Garner, Elaine M. Phillips and Adam K. Simpson in March 2008 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Director/Board Member | |
| SUPERNUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member | |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Director/Board Member | |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
| ECHO GLOBAL LOGISTICS, INC. | Trucking | Corporate Officer/Principal | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 46 |
| Vereinigtes Königreich | 4 |
| Schweiz | 2 |
Sektoral
| Health Technology | 36 |
| Consumer Services | 8 |
| Finance | 3 |
| Health Services | 3 |
| Retail Trade | 2 |
Operativ
| Director/Board Member | 268 |
| Corporate Officer/Principal | 97 |
| Independent Dir/Board Member | 81 |
| Chairman | 48 |
| Founder | 46 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| James Blair | 48 |
| Brian Atwood | 40 |
| Paul Klingenstein | 34 |
| Cam Garner | 28 |
| Ginger Graham | 27 |
| Judith Ann Hemberger | 26 |
| Jay Moorin | 21 |
| John Reed | 20 |
| Andrew Allen | 18 |
| Keith Flaherty | 16 |
| Julie Hambleton | 15 |
| Robert Azelby | 15 |
| Jay Backstrom | 15 |
| Thorlef Spickschen | 14 |
- Börse
- Insiders
- Edward McKinley
- Unternehmensverbindungen
